Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Dr Wissam A Jaber Added: 1 year ago
TCT Conference 24 - PEERLESS II shows benefit of large-bore mechanical thrombectomy compared to catheter-directed thrombolysis for intermediate-risk pulmonary embolism (PE) patients.Dr Wissam A Jaber (Emory University Hospital Midtown, US) joins us onsite at TCT Conference to discuss the findings from PEERLESS (NCT06055920; Inari Medical).PEERLESS is a prospective, multicenter, randomized… View more
Author(s): Stefan Stortecky Added: 1 year ago
CRT 25 - Outcomes in patients with intermediate-risk pulmonary embolism (PE) with contraindications to thrombolytics show large-bore mechanical thrombectomy is a safe and effective treatment option for this comorbid patient population. In the contraindication cohort, large-bore mechanical thrombectomy was successfully performed with no in-hospital mortality or intracranial haemorrhage.Dr Stefan… View more
Author(s): Stavros Konstantinides , José M Montero-Cabezas , Mario Iannaccone , et al Added: 6 months ago
This expert-led, on-demand programme explores the latest evidence and interventional strategies for intermediate-high and high-risk pulmonary embolism (PE). Chaired by Prof Stavros Konstantinides (University of Mainz, Mainz, DE) and featuring renowned specialists Dr José Montero-Cabezas (Leiden University Medical Center, Leiden, NL), Dr Mario Iannaccone (Turin Nord Emergency Hospital, Turin, IT)… View more
Author(s): Oliver Schlager Added: 9 months ago
ESC Congress 2025 - New guidelines for catheter-based VTE therapy emphasise the importance of involving vascular experts, and performing procedures in experienced centers.Dr Oliver Schlager (Medical University of Vienna, AT) joins us to discuss the newly released 2025 ESVM Guidelines on Interventional Treatment of Venous Thromboembolism, endorsed by European national societies of Vascular… View more
Author(s): Nicolas M Van Mieghem Added: 1 month ago
In this EuroPCR 2026 preview, Prof Nicolas Van Mieghem (Erasmus University, NL) provides an in-depth look at the most anticipated late-breaking trials, translating emerging data into actionable takeaways for interventional practice.Focusing on the management of heavily calcified coronary disease, structural innovations, and mechanical support, he walks through the design and potential real-world… View more
Research Area(s) / Expertise:
Dr Sandeep Nathan is currently the director of the coronary care unit at the University of Chicago Medicine in Illinois. He specializes in interventional cardiology, regularly performing coronary and peripheral vascular procedures, including transradial angiography. His research interests include balloon angioplasty, stenting, atherectomy, thrombectomy, cryoplasty and IVUS imaging. Dr Nathan… View more
Author(s): Nicolas M Van Mieghem Added: 1 month ago
In this EuroPCR 2026 preview, Prof Nicolas Van Mieghem (Erasmus University, NL) walks through the most anticipated late-breaking trials across calcified coronary disease, structural heart intervention, and mechanical support — from laser-based IVL and atherectomy comparisons to three-year TAVI outcomes, tricuspid repair, high-risk PCI, and pulmonary embolism therapy.Editor: Mirjam Boros View more
Author(s): Stavros Konstantinides, Sylwia Sławek-Szmyt, José M Montero-Cabezas ,et al Start date: Dec 04, 2025
STORM-PE: Novel Data Driving Change in PE TreatmentJoin us for an exclusive webinar chaired by Prof Konstantinides (Mainz, DE), offering a focused exploration of advanced treatment strategies for intermediate-high and high-risk pulmonary embolism (PE). Together with leading experts Dr Montero-Cabezas (Leiden, NL), Dr Iannaccone (Turin, IT) and Dr Sławek-Szmyt (Poznan, PL), this session will… View more